SEC Form 4 · accession 0001127602-15-014191
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wayne S DeVeydt
Officer — EVP & Chief Financial Officer
Period of report
Apr 6, 2015
Accepted (ET)
Apr 8, 2015 · 4:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 6, 2015 | M | 37,012 | $66.23 | A | 156,475 | D | |
| Common Stock | Apr 6, 2015 | M | 27,873 | $61.88 | A | 184,348 | D | |
| Common StockF2 | Apr 6, 2015 | S | 10,528 | $153.17 | D | 173,820 | D | |
| Common StockF3 | Apr 6, 2015 | S | 13,790 | $154.63 | D | 160,030 | D | |
| Common StockF4 | Apr 6, 2015 | S | 77,904 | $155.50 | D | 82,126 | D | |
| Common StockF5 | Apr 6, 2015 | S | 12,519 | $155.97 | D | 69,607 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F6 | $66.23 | Apr 6, 2015 | M | 37,012 | D | — | Mar 1, 2019 | Common Stock | 37,012 | 0 | D |
| Employee Stock Option (Right to Buy)F7 | $61.88 | Apr 6, 2015 | M | 27,873 | D | — | Mar 1, 2020 | Common Stock | 27,873 | 13,938 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2015.
- F2This transaction was executed in multiple trades at prices ranging from $152.90 to $153.89. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $153.90 to $154.89. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $154.90 to $155.89. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $155.90 to $156.04. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6The option, representing a right to purchase a total of 37,012 shares, became exercisable in two equal semi-annual installments of 6,168 shares each and four equal semi-annual installments of 6,169 shares each beginning on September 1, 2012, which was the six-month anniversary of the date on which the option was granted.
- F7The option, representing a right to purchase a total of 41,811 shares, became exercisable in three equal semi-annual installments of 6,968 shares each and three equal semi-annual installments of 6,969 shares each beginning on September 1, 2013, which was the six-month anniversary of the date on which the option was granted.